POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU

Stopped early · Phase 2

Conditions studied: Uveitis Posterior Non-Infectious, Uveitis, Intermediate, Noninfectious Panuveitis

In brief

This is a multi-center, randomized, double-masked, proof-of-concept study in patients with Active Noninfectious Intermediate, Posterior, or Panuveitis.

Key facts

Study ID

NCT05953688

Run by

Alumis Inc

People needed

36

Starts

2023-06-14

Expected to finish

2024-08-13

Last updated by the study team

2024-08-28

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Investigator Site#1065 — Beverly Hills, California, United States
• Investigator Site #1073 — Los Angeles, California, United States
• Investigator Site #1072 — Los Angeles, California, United States
• Investigator Site #1080 — Palo Alto, California, United States
• Investigator Site #1079 — Sacramento, California, United States
• Investigator Site#1068 — Lakewood, Colorado, United States
• Investigator Site #1086 — Oak Park, Illinois, United States
• Investigator Site #1085 — Hagerstown, Maryland, United States
• Investigator Site #1069 — Waltham, Massachusetts, United States
• Investigator Site #1076 — Palisades Park, New Jersey, United States
• Investigator Site #1083 — Durham, North Carolina, United States
• Investigator Site #1064 — Erie, Pennsylvania, United States
• Investigator Site#1066 — Nashville, Tennessee, United States
• Investigator Site #1084 — Nashville, Tennessee, United States
• Investigator Site#1075 — Bellaire, Texas, United States
• Investigator Site #1074 — Katy, Texas, United States
• Investigator Site #1078 — Plano, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.